Apitolisib (RG 7422), an effective, class I PI3K inhibitor for PI3Kalpha(IC50=5 nM), PI3Kbeta(IC50=27 nM), PI3Kdelta(IC50=7 nM), PI3Kgamma (IC50=14 nM), is used in trials study of solid cancers, breast cancer, prostate cancer, renal cell carcinoma, and endometrial carc
Molecular Weight:
498.6
CAS Number:
[1032754-93-0]
Formula:
C23H30N8O3S
Target:
mTOR|||Apoptosis|||PI3K
* VAT and and shipping costs not included. Errors and price changes excepted